William H Rastetter sold $2.7M of Neurocrine Biosciences (NBIX)

Executed Nov 5 2025, disclosed Nov 6 2025, 1 day later.

Value, as filed

$2.7M

18,000 sh × $151.82

Executed

Nov 5 2025

the trade date, as filed

Disclosed

Nov 6 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

WR William H Rastetter Director profile →

William H Rastetter (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.7M of NBIX (18,000 sh × $151.82, as filed), executed Nov 5 2025.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by William H Rastetter in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $3.3M
30,000 sh × $110.20
Exec May 5 2025
Filed May 7 2025 · 5:30 PM ET